Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd
Nearly half of patients dosed with Merck and Daiichi Sankyo’s ifinatamab deruxtecan responded to the treatment, helping the partners mount...
Nearly half of patients dosed with Merck and Daiichi Sankyo’s ifinatamab deruxtecan responded to the treatment, helping the partners mount...
In a groundbreaking study set to reshape oncology, a multinational team of researchers has launched a pioneering trial called DigiNet,...
Newswise — MONTCLAIR, N.J. (September 9, 2024) – Hackensack Meridian Mountainside Medical Center has announced a strategic partnership with Eon, a...
A large-scale survey conducted by Lung Cancer Europe (LuCE) has identified critical communication barriers that affect information access, understanding, and...
Australia’s first National Lung Cancer Screening Program (NLCSP) commenced on 1 July 2025, marking a landmark public health initiative aimed...
An investigation into the $368 billion AI healthcare revolution — and the visionary CEO determined to make cancer a preventable...
Study characteristics and LCS participationOver 110 million participants (110,999,150) were included across seven reviews (n = 2,988,779) (Table 1, Fig. 2A) and 54 recent and...
NYC Health + Hospitals/Kings County Awarded Designation as Center of Excellence in Lung Cancer Screening GO2 for Lung...
Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker testing. CHICAGO, Aug. 20,...